Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vocacapsaicin (CA-008) in Total Knee Arthroplasty
NCT03731364Phase 2Completed
- Sponsor
- Concentric Analgesics, Inc.
- Start
- Oct 2018
- Primary completion
- Apr 2019
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vocacapsaicin in Persistent postsurgical pain (PPSP) (5 arms), sponsored by Concentric Analgesics, Inc. Primary endpoints: Time-specific Mean Pain Intensity Scores (NRS) at 96 hours and Area Under the Curve (AUC) for Pain Intensity. Started Oct 2018; status: completed.
02
Drugs
vocacapsaicin
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT03731364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03731364.